Person in custody after reported shooting at CIA headquarters
The CIA have decline to say whether suspect was hit by gunfire, and the individual is now in custody.
The CIA now concludes COVID-19 is "more likely" to have originated from a Wuhan lab, though with "low confidence." This aligns with the FBI and DOE, sparking renewed debate as China rejects the claim. The origins remain contested, influencing global health and diplomacy.
In a significant development, the Central Intelligence Agency (CIA) has revised its stance on the origins of the COVID-19 pandemic, now concluding that the virus is "more likely" to have originated from a laboratory in Wuhan, China.
This shift aligns the CIA with other U.S. intelligence agencies, including the Federal Bureau of Investigation (FBI) and the Department of Energy, both of which have leaned toward the lab leak theory. However, the CIA's assessment comes with a caveat; it remains made with "low confidence," indicating that the evidence supporting this conclusion is not definitive.
The agency’s reassessment marks a departure from earlier uncertainty, with the CIA previously refraining from taking a clear position on how the virus first emerged. This new perspective has ignited further debate on the virus’s origins, which has been a contentious issue since COVID-19 first emerged in Wuhan in late 2019.
The CIA’s conclusion is the result of ongoing analysis, but the agency has not detailed any new intelligence that would conclusively support the lab leak theory. It stresses that it continues to consider both the lab leak and natural origin scenarios as plausible and is evaluating new information as it becomes available. The U.S. government’s intelligence community has yet to provide definitive proof for either theory.
This development also follows the appointment of John Ratcliffe as the CIA Director. Ratcliffe, who served as Director of National Intelligence under President Donald Trump, has been a vocal proponent of the lab leak hypothesis. His leadership has likely played a role in the agency's renewed focus on investigating the virus's origins.
The Chinese government has rejected the lab leak theory, reiterating its long-standing position that there is no evidence to support it. Chinese officials have dismissed the theory as "absurd" and accused certain foreign governments of politicizing the issue.
Spokesperson Mao Ning expressed the belief that some countries are using the lab leak theory as a pretext to criticize China, especially as the pandemic’s global impact continues to affect millions.
The Chinese government also referenced the conclusions of the World Health Organization (WHO), which had previously investigated the origins of the virus and found no conclusive evidence to support the lab leak theory. Instead, the WHO investigation leaned toward the possibility that the virus had a natural origin, likely jumping from animals to humans, potentially through an intermediary species.
Reaffirming their rejection of the lab leak theory, Chinese authorities have accused the U.S. of trying to deflect blame for the global crisis. They argue that the U.S. is attempting to shift focus from its own handling of the pandemic by politicizing scientific debates and fostering distrust about the virus’s origins.
Beijing has continued to call for further international cooperation in understanding how COVID-19 began, emphasizing that such inquiries should remain scientific and free from political interference.
Despite China's denials, other U.S. intelligence agencies, including the FBI and the Department of Energy, have supported the lab leak hypothesis. This is a significant shift in the U.S. intelligence community, which previously remained divided on the issue. The CIA's new position has added fuel to the debate, with some experts and officials arguing that the U.S. should press China for greater transparency about the virus's origins.
The Chinese government, however, has remained firm in its refusal to provide full access to critical data, citing the need for unbiased and scientific investigations.
The CIA’s revised conclusion is expected to influence ongoing global discussions and investigations into the origins of COVID-19. The matter continues to be a pivotal issue in international relations and global health policy, with ramifications for both scientific inquiry and diplomatic relations.
As the investigation continues, the consensus remains divided on whether COVID-19 emerged from a natural spillover event or from a laboratory incident.
Taxi drivers across France are protesting government plans to cut payments for driving patients to medical appointments. These cuts are part of a broader effort by Prime Minister François Bayrou to save €40 billion in the 2026 budget and reduce the country’s large deficit.
Brazil’s economy is expected to have regained momentum in the first quarter of 2025, driven by a surge in household spending and private investment, according to a Reuters poll of economists conducted from May 21–26.
As peace talks progress, voices from Yerevan, Tbilisi, and Baku reveal hopes, concerns, and expectations for a future shaped by trade, trust, and generational change in the South Caucasus.
In a major blow to one of President Donald Trump’s key economic policies, a US federal court has blocked the administration’s sweeping global tariff regime, ruling that the White House overstepped its constitutional authority.
A bridge collapse in the Vygonichsky district of Russia’s Bryansk region, near the Ukrainian border, caused a train derailment and a traffic accident early Sunday, killing at least seven people and leaving 30 injured, according to emergency services.
Radionuclide therapy using the radioactive element terbium shows promising potential in treating lymphoma, according to recent experimental results from the Paul Scherrer Institute (PSI) in collaboration with Inselspital – Bern University Hospital.
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
The UK has officially banned the sale of disposable vapes as of Sunday, aiming to curb youth usage, reduce environmental waste, and stop the spread of harmful chemicals.
The U.S. FDA has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults aged 65 and older and those aged 12–64 with risk factors, marking a major step under tighter regulations.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment